These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32853641)

  • 1. Extra-cranial factors in the development of Alzheimer's disease.
    Eiser AR; Fulop T
    Brain Res; 2020 Dec; 1748():147076. PubMed ID: 32853641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
    Liu S; Gao J; Zhu M; Liu K; Zhang HL
    Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway.
    Haran JP; Bhattarai SK; Foley SE; Dutta P; Ward DV; Bucci V; McCormick BA
    mBio; 2019 May; 10(3):. PubMed ID: 31064831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis and Alzheimer's Disease: A Role for Chronic Stress?
    Sharma VK; Singh TG; Garg N; Dhiman S; Gupta S; Rahman MH; Najda A; Walasek-Janusz M; Kamel M; Albadrani GM; Akhtar MF; Saleem A; Altyar AE; Abdel-Daim MM
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33946488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota, Its Role in Induction of Alzheimer's Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins.
    Khan MS; Ikram M; Park JS; Park TJ; Kim MO
    Cells; 2020 Apr; 9(4):. PubMed ID: 32244729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-celiac gluten sensitivity triggers gut dysbiosis, neuroinflammation, gut-brain axis dysfunction, and vulnerability for dementia.
    Daulatzai MA
    CNS Neurol Disord Drug Targets; 2015; 14(1):110-31. PubMed ID: 25642988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's Disease Is a Multi-Organ Disorder: It May Already Be Preventable.
    Eiser AR; Fulop T
    J Alzheimers Dis; 2023; 91(4):1277-1281. PubMed ID: 36617785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Muscle-Gut-Brain Axis": Can Physical Activity Help Patients with Alzheimer's Disease Due to Microbiome Modulation?
    Schlegel P; Novotny M; Klimova B; Valis M
    J Alzheimers Dis; 2019; 71(3):861-878. PubMed ID: 31476155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.
    Grammas P
    J Neuroinflammation; 2011 Mar; 8():26. PubMed ID: 21439035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration.
    Lazar E; Sherzai A; Adeghate J; Sherzai D
    Front Biosci (Schol Ed); 2021 Jun; 13(1):17-29. PubMed ID: 34256527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
    Brandl K; Schnabl B
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.
    Sochocka M; Donskow-Łysoniewska K; Diniz BS; Kurpas D; Brzozowska E; Leszek J
    Mol Neurobiol; 2019 Mar; 56(3):1841-1851. PubMed ID: 29936690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Gut Microbiota in Health and Alzheimer's Disease.
    Szablewski L
    J Alzheimers Dis; 2018; 62(2):549-560. PubMed ID: 29480188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease.
    Minter MR; Zhang C; Leone V; Ringus DL; Zhang X; Oyler-Castrillo P; Musch MW; Liao F; Ward JF; Holtzman DM; Chang EB; Tanzi RE; Sisodia SS
    Sci Rep; 2016 Jul; 6():30028. PubMed ID: 27443609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?
    Megur A; Baltriukienė D; Bukelskienė V; Burokas A
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
    Chopyk DM; Grakoui A
    Gastroenterology; 2020 Sep; 159(3):849-863. PubMed ID: 32569766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K2 Holds Promise for Alzheimer's Prevention and Treatment.
    Popescu A; German M
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34199021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.